
Melanoma Starts Evading Treatment Within Hours – Here’s How to Stop It
ISB researchers have uncovered a stealth survival strategy that melanoma cells use to evade targeted therapy, offering a promising new approach to improving treatment outcomes.
Institute for Systems Biology
James R. Heath, PhD, is president and professor of Institute for Systems Biology in Seattle.
The Heath group is made up of postdoctoral fellows, graduate students, research associates, and more.
We are always looking for talented students and postdocs.
Jim Heath and his lab members publish several papers in various journals each year.
The Heath Group uses an optical imaging lab, a clean room microfab facility, peptide/chemistry tools, and more.
The Heath Lab works on scientific bottlenecks that, if solved, can provide keys toward larger problems.
ISB researchers have uncovered a stealth survival strategy that melanoma cells use to evade targeted therapy, offering a promising new approach to improving treatment outcomes.
Scientists at the Institute for Systems Biology (ISB) reveal how T cells “decide” their fate in fighting infections like COVID-19, paving the way for improved treatments for infections, cancer, and autoimmune diseases.
ISB hosted a virtual event to share updates on the ongoing RECOVER study, a national NIH-funded initiative to understand and address Long COVID.